Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASP2151 Phase 1 Study - Multiple Oral Dosing Study in Healthy Non-elderly Male and Elderly Male Japanese Subjects-

NCT02796118 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02796118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02796118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASP2151 Phase 1 Study - Multiple Oral Dosing Study in Healthy Non-elderly Male and Elderly Male Japanese Subjects-
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2006
Completion date
October 31, 2006
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects